Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
Study Evaluating Safety and Efficacy of UCART Targeting CS1 in Patients With Relapsed/Refractory Multiple Myeloma (MELANI-01)
ClinicalTrials.gov study NCT04142619. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of CC-93269, a BCMA x CD3 T Cell Engaging Antibody, in Participants With Relapsed and Refractory Multiple Myeloma
ClinicalTrials.gov study NCT03486067. IPD Sharing: Not stated. Countries: 6. Publications: 0.
Study of Carfilzomib, Cyclophosphamide and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients
ClinicalTrials.gov study NCT02204241. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Investigate the Safety and Efficacy of TEG002 in Relapsed/Refractory Multiple Myeloma Patients
ClinicalTrials.gov study NCT04688853. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Steroid Sparing Treatment With in Newly Diagnosed Transplant Ineligible Patients With Multiple Myeloma
ClinicalTrials.gov study NCT04635189. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study of ARRY-520 and Bortezomib Plus Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT01248923. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 1 With Extension Cohort, Single Arm, Single Center, Open Label Trial of Belantamab Mafodotin for the Treatment of High-Risk Smoldering Multiple Myeloma
ClinicalTrials.gov study NCT05055063. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Virtual Exercise for Multiple Myeloma
ClinicalTrials.gov study NCT04484714. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Study of SGN-40, Lenalidomide, and Dexamethasone in Patients With Multiple Myeloma
ClinicalTrials.gov study NCT00525447. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Exercise Therapy for Multiple Myeloma Patients
ClinicalTrials.gov study NCT07388147. IPD Sharing: YES. Countries: 1. Publications: 0.
A Comparative Clinical Study to Determine the Optimal Initial Therapy for Multiple Myeloma
ClinicalTrials.gov study NCT06151717. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Investigate eNAMPT in Multiple Myeloma Biology and Establish Its Role in Disease Progression
ClinicalTrials.gov study NCT04137523. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Lenalidomide and Pidilizumab in Treating Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT02077959. IPD Sharing: NO. Countries: 1. Publications: 0.
Relevance Evaluation of [68Ga]Ga-PentixaFor for Initial Staging and Detection of Minimal Residual Disease in Multiple Myeloma Patients.
ClinicalTrials.gov study NCT05321862. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Evaluation of PET 18F-Fludarabine for the Initial Assessment and End-treatment of Symptomatic Multiple Myeloma Patients
ClinicalTrials.gov study NCT03832127. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
This is an Open-label, Single Arm Study to Evaluate the Safety and Tolerability of Treatment With CT0591CP in Patients With Relapsed and/or Refractory Multiple Myeloma.
ClinicalTrials.gov study NCT05486975. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Incidence of Hyperpigmentation in Black Patients With Multiple Myeloma Treated With Immunomodulatory Drugs
ClinicalTrials.gov study NCT06160167. IPD Sharing: NO. Countries: 1. Publications: 0.
Personalized Autologous Transplant for Multiple Myeloma
ClinicalTrials.gov study NCT04483206. IPD Sharing: NO. Countries: 1. Publications: 0.
Retrospective Viability Study of the PETHEMA-POMCIDEX Clinical Practice Guidelines for the Treatment of Patients With Relapsed and Refractory Multiple Myeloma (RRMM)
ClinicalTrials.gov study NCT03477643. IPD Sharing: NO. Countries: 1. Publications: 0.
Development of a Standardized Reference Guide for Tuning Adherence to Dispense During a Initial Pharmaceutical Consulting (CP ) to the Patient With Multiple Myeloma Oral Chemotherapy Primocure
ClinicalTrials.gov study NCT04045561. IPD Sharing: Not stated. Countries: 0. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.